Hims & Hers Health (CHIX:82WD) Ending Cash Position: €222 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:82WD Hims & Hers Health Inc CHIX:82WD
60 GF Score
Price €30.46
GF Value €34.24
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Hims & Hers Health Ending Cash Position?

Hims & Hers Health CHIX:82WD 60 Ending Cash Position is €222 Mil as of Mar. 2026. GuruFocus rates CHIX:82WD with a GF Score™ of 60/100 and a GF Value™ of €34.24 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Hims & Hers Health's Ending Cash Position for the quarter that ended in Mar. 2026 was €222 Mil.

Hims & Hers Health's quarterly Ending Cash Position declined from Sep. 2025 (€346 Mil) to Dec. 2025 (€229 Mil) and declined from Dec. 2025 (€229 Mil) to Mar. 2026 (€222 Mil).

Hims & Hers Health's annual Ending Cash Position increased from Dec. 2023 (€98 Mil) to Dec. 2024 (€221 Mil) and increased from Dec. 2024 (€221 Mil) to Dec. 2025 (€229 Mil).

Hims & Hers Health Ending Cash Position Related Terms

Hims & Hers Health Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Hims & Hers Health's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hims & Hers Health Ending Cash Position Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 72.64 47.63 97.52 221.44 228.62

Hims & Hers Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 274.96 1,124.95 345.78 228.62 222.27
CHIX:82WD
60GF Score
Hims & Hers Health Inc CHIX:82WD
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hims & Hers Health Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Hims & Hers Health's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=221.44+7.1759999999999
=229

Hims & Hers Health's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=228.616+-6.35
=222

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of €222 Mil mean?
Hims & Hers Health (CHIX:82WD) has a Ending Cash Position of €222 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Hims & Hers Health and its competitors.
Is Hims & Hers Health's Ending Cash Position too high?
Hims & Hers Health's current Ending Cash Position is €222 Mil. Overall, Hims & Hers Health has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's Ending Cash Position compare to ?
Hims & Hers Health's Ending Cash Position of €222 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Hims & Hers Health and its competitors. Hims & Hers Health's current Ending Cash Position is €222 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Based on GuruFocus' analysis, Hims & Hers Health (CHIX:82WD) is currently considered Modestly Undervalued. The stock's GF Value™ is €34.24, compared to a current price of €30.46 — trading 11% below its estimated fair value. The current Ending Cash Position is €222 Mil. Hims & Hers Health's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Hims & Hers Health (CHIX:82WD), the current Ending Cash Position is €222 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hims & Hers Health (CHIX:82WD) Overvalued in 2026?

Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued. The current stock price of €30.46 is trading 11% below its estimated GF Value™ of €34.24. GuruFocus considers Hims & Hers Health to be Modestly Undervalued.

Key valuation signals for CHIX:82WD:

  • Ending Cash Position: €222 Mil
  • GF Value™: €34.24 vs. price of €30.46 (11% below fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the CHIX:82WD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hims & Hers Health Business Description

Comparable Companies
Address 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
60GF Score

Get the complete analysis for CHIX:82WD

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€30.46
Price
€34.24
GF Value